Marco Antonio Stephano
Sao Paulo University, Brazil
Posters-Accepted Abstracts: J Bioproces Biotechniq
The development of protein pharmaceuticals after the discovery of their biological activity is often considered to be easier than the development of conventional pharmaceuticals since most such proteins are found in the human body and therefore pose few safety concerns beyond the biological activity. On the other hand, development of the formulation and fill-finish process for proteins has been much more challenging, as they have only marginal stability during routine pharmaceutical handling conditions. In addition, proteins are difficult to deliver systemically by noninvasive routes due to their poor bioavailability. Proteins� marginal stability and the strong preference of a parenteral delivery route make freeze-drying a common means for manufacturing protein products. Lyophilization or freeze-drying consists of three steps: freezing, primary drying and secondary drying. One critical parameter for an effective drying is the temperature that sample collapses (Tc) or presents a glass (Tg)/crystalline melting transition (Te). Primary drying settings below Tc/Tg avoid collapse of the freeze-dried cake, which may cause: higher residual moisture, lengthy reconstitution times or even loss of biological activity. Hence, thermal characterization is essential to screen the best formulation. When a formula collapses or changes its physicochemical and biological properties throughout the process, a protective excipient is needed to perform the drying without product damage. Excipients can confer cryo-protection and lyo-protection, depending on whether the protection occurs during freezing or drying, respectively. Other functions can also optimize the outcome, as bulking agents, buffers and protein stabilizers.
Email: stephano@usp.br
Journal of Bioprocessing & Biotechniques received 3351 citations as per Google Scholar report